Evidence map›Paper›PMID 33183068›Full record

Trial reportExperimental biology and medicine (Maywood, N.J.)2021

Treatment of osteoporosis with a modified zeolite shows beneficial effects in an osteoporotic rat model and a human clinical trial.

Sandra Kraljević Pavelić, Vedran Micek, Dragica Bobinac, Edo Bazdulj, Alessandra Gianoncelli, Dalibor Krpan, Marta Žuvić, Sandra Eisenwagen, Peter J Stambrook, Krešimir Pavelić

Erratum issuedOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Experimental biology and medicine (Maywood, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. PMA-Zeolite: Chemistry and Diverse Medical Applications.Journal of functional biomaterials · 2024
    Review
  5. Nanoparticles in Medicine: Current Status in Cancer Treatment.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Zeolites: A series of promising biomaterials in bone tissue engineering.Frontiers in bioengineering and biotechnology · 2022
    Review
  12. In Silico Network Analysis of Ingredients of Cornus officinalis in Osteoporosis.Medical science monitor : international medical journal of experimental and clinical research · 2021
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Sandra Kraljević PavelićFaculty of Health Studies, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0003-0491-673X
Vedran MicekInstitute for Medical Research and Occupational Health, 10001 Zagreb, Croatia.
Dragica BobinacDepartment of Anatomy, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Edo BazduljDepartment of Anatomy, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Alessandra GianoncelliELETTRA - Sincrotrone Trieste, I-34149 Trieste-Basovizza, Italy.ORCID 0000-0002-2457-3618
Dalibor KrpanPolyclinic "K - Center," for Internal Medicine, Gynecology, Radiology, Physical Medicine and Rehabilitation, 10 000 Zagreb, Croatia.
Marta ŽuvićDepartment of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.
Sandra EisenwagenPanaceo International GmbH, A-9585 Godersdorf, Austria.
Peter J StambrookCollege of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
Krešimir PavelićFaculty of Medicine, Juraj Dobrila University of Pula, 52100 Pula, Croatia.
University of Rijeka · HRElettra-Sincrotrone Trieste S.C.p.A. · ITInstitute for Medical Research and Occupational Health · HRJuraj Dobrila University of Pula · HRUniversity Hospital Centre Zagreb · HRUniversity of Cincinnati Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The severity of osteoporosis in humans manifests in its high incidence and by its complications that diminish quality of life. A societal consequence of osteoporosis is the substantial burden that it inflicts upon patients and their families. Several bone-modifying drugs have been prescribed to patients with osteoporosis. However, evidence for their anti-fracture efficacy remains inconclusive. To the contrary, long-term use of anti-osteoporotic drugs such as bisphosphonates and Denosumab, an RANKL inhibitor, have resulted in adverse events. We now present an alternative and adjuvant approach for treatment of osteoporosis. The data derive from

Indexed as

AgedAnimalsBiomarkersBone DensityDisease Models, AnimalFemaleHumansMaleMiddle AgedOsteoporosisOvariectomyRatsRats, WistarTibiaX-Ray MicrotomographyZeolitesBiomarkersZeolitesclinoptilolite Panaceo Micro Activationclinoptilolite tuffdouble-blinded clinical trialosteoporosisovariectomized ratsZeolite

Identifiers

PMID33183068
PMCPMC7930600
OpenAlexW3104661791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.